Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 2,525.00
-125.00 (-4.72%)
Jun 30, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 114.84 billion as of June 30, 2026. Its market cap has decreased by -48.57% in one year.
Market Cap
114.84B
Enterprise Value
n/a
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,525.00
Market Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 114.84B, an increase of 5.34%. That is a compound annual growth rate of 0.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 114.84B | -46.10% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 185.13B |
| Bioneer | 176.54B |
| NeoImmuneTech | 130.11B |
| Macrogen | 129.77B |
| Vaxcell-Bio Therapeutics | 118.85B |
| MedPacto | 107.80B |
| Amicogen | 104.34B |
| ENCell | 84.82B |